EGFR and non-small cell lung carcinoma: Methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit (METTL 14)-mediated N6-methyladenosine (m6A) modification of Bim messenger RNA (mRNA) enhances the sensitivity of EGFR-mutated NSCLC cells to osimertinib[98].